Endovascular treatment with interwoven nitinol stent for common femoral artery lesions: 2-year outcomes of a single center experience

CONCLUSION: Endovascular treatment with interwoven nitinol (Supera™) stent for CFA lesions was associated with acceptable outcomes at 2 years.PMID:38409957 | DOI:10.1177/17085381241236564
Source: Vascular - Category: Surgery Authors: Source Type: research